Chemotherapy in the Management of Metastatic Cancer of Unknown Primary Site

Abstract
The incidence of metastatic malignancy of unknown origin was approximately 3 %. The extent of investigation to determine the primary site was strongly influenced by estimating the probability that additional information would significantly change the treatment. Treatment regimens are described.

This publication has 0 references indexed in Scilit: